Food Allergy Therapeutic Pipeline Reviewed in Topical Global Markets Direct Study Published at MarketPublishers.com
24 Jul 2013 • by Natalie Aster
LONDON – Worldwide, food allergies are on the increase, and their main manifestations include, among others, atopic dermatitis, anaphylaxis, and eosinophilic gastrointestinal disorders. Factors contributing to the hike in food allergies include the high survivorship of atopic subjects allowing the spread of the genetic traits; use of antacids; caesarean section deliveries; the hygiene hypothesis; and use of infant multivitamins.
There are three major approaches to the treatment of food allergy in development: anti-IgE antibodies, immunotherapy and Chinese herbal remedy. However, with more and more novel therapies being developed on a continuous basis, strict avoidance of the food that causes allergy remains the most effective treatment so far.
Topical study “Food Allergy - Pipeline Review, H1 2013” created by Global Markets Direct provides an insightful overview of the global therapeutic scenario for food allergy. It reviews the food allergy products under development by companies and different research organisations; examines the products being in various phases of development – from discovery till registration; covers pipeline projects on the basis of monotherapy and combined therapeutics; analyses the food allergy pipeline in terms of route of administration and molecule type; uncovers the discontinued projects, besides looking into the factors that drove them from pipeline. Furthermore, the emerging players with potentially strong product portfolio are identified, and the latest news and deals relating to the products are highlighted in the research report.
Food Allergy - Pipeline Review, H1 2013
Published: June, 2013
Price: US$ 2,000.00
Other Diseases Pipeline Reviews H1 2013 by Global Markets Direct Include:
- Hemorrhagic Fever - Pipeline Review, H1 2013
- Hearing Disorders - Pipeline Review, H1 2013
- General Anxiety Disorder - Pipeline Review, H1 2013
- Eye Infections - Pipeline Review, H1 2013
- Diabetic Peripheral Neuropathy - Pipeline Review, H1 2013
- Degenerative Disc Disease - Pipeline Review, H1 2013
More topical studies by the publisher can be found at Global Markets Direct page.